ClinicalTrials.govpublic full text
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
hepatocellular carcinoma, liver transplantation, lenvatinib, adjuvant therapy, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900882
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.